Sun, Bin
Zhang, Tikai
Chen, Hongrui
Gao, Wei
Zhou, Jingwei
Chen, Yuxi
Ding, Wang
Yin, Xiaofan
Ren, Jie
Hua, Chen
Lin, Xiaoxi
Funding for this research was provided by:
Shanghai Sailing Program (22YF1421900)
Major and Key Cultivation Projects of Ninth People's Hospital affiliated to Shanghai Jiao Tong University School of Medicine (JYZP005)
Efficacy and mechanism study of WX390 in PIK3CA-Related Overgrowth Spectrum (JYWO22075)
Fundamental Research Funds for the Central Universities (YG2023ZD13)
Article History
Received: 16 January 2024
Accepted: 16 May 2024
First Online: 25 June 2024
Declarations
:
: All protocols involving human subjects were reviewed and approved by the Institutional Review Board of Shanghai Ninth People’s Hospital. All animal experiments were reviewed and approved by Shanghai Ninth People's Hospital Central Lab IACUC (Permit Number: SYXK (Shanghai) 2016-0016), and all experiments conformed to the relevant regulatory standards.
: All authors have provided consent for the manuscript to be published in Journal of Nanobiotechnology.
: The authors declare that they have no competing interests.